Molecular pathology - The value of an integrative approach

Molecular Oncology

Volumn 8, Issue 7, 2014, Pages 1163-1168

  Salto Tellez, Manuel ^a,b   James, Jacqueline A ^a,b   Hamilton, Peter W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Molecular diagnostics; Molecular pathology; Translational research

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

MODEL; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; PATHOLOGIST; REVIEW; SOLID TUMOR; TECHNOLOGY; TRANSLATIONAL RESEARCH; VALIDATION STUDY; ANIMAL; BIOLOGY; HEALTH CARE FACILITY; HUMAN; NEOPLASMS; PATHOLOGY; PROCEDURES;

ANIMALS; COMPUTATIONAL BIOLOGY; HUMANS; NEOPLASMS; PATHOLOGY, MOLECULAR; TISSUE BANKS; TRANSLATIONAL MEDICAL RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 84908396051     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.07.021     Document Type: Review

References (18)

1. Bai Y., Cheng H., Bordeaux J., Neumeister V., Kumar S., Rimm D.L., Stern D.F. Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method. PLoS One 2013, 8(11):e79901.
2. Chan J.Y., Salto-Tellez M. Opinion: molecular gestalt and modern pathology. Adv. Anat. Pathol. 2012, 19(6):425-426.
3. Dietel M., Jöhrens K., Laffert M., Hummel M., Bläker H., Müller B.M., Lehmann A., Denkert C., Heppner F.L., Koch A., Sers C., Anagnostopoulos I. Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. Cancer Gene Ther. 2013, 20(4):211-221.
4. Dorsey D.B. Evolving concepts of quality in laboratory practice. A historical overview of quality assurance in clinical laboratories. Arch. Pathol. Lab. Med. 1989, 113(12):1329-1334.
5. Drucker E., Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. E.P.M.A. J. 2013, 4(1):7.
6. Flynn C., James J., Maxwell P., McQuaid S., Ervine A., Catherwood M., Loughrey M.B., McGibben D., Somerville J., McManus D.T., Gray M., Herron B., Salto-Tellez M. Integrating molecular diagnostics into histopathology training: the Belfast model. J.Clin. Pathol. 2014, 67(7):632-636. 10.1136/jclinpath-2014-202176.
7. Harris T.J., McCormick F. The molecular pathology of cancer. Nat. Rev. Clin. Oncol. 2010, 7(5):251-265.
8. Lauwers G.Y., Black-Schaffer S., Salto-Tellez M. Molecular pathology in contemporary diagnostic pathology laboratory: an opinion for the active role of surgical pathologists. Am. J. Surg. Pathol. 2010, 34(1):115-117.
9. McCourt C.M., McArt D.G., Mills K., Catherwood M.A., Maxwell P., Waugh D.J., Hamilton P., O'Sullivan J.M., Salto-Tellez M. Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis. PLoS One 2013, 8(7):e69604. 10.1371/journal.pone.0069604.
10. Muley T., Herth F.J.F., Schnabel P., Dienemann H., Meister M. From tissue to molecular phenotyping: pre-analytical requirements Heidelberg Experience. Transl. Lung Cancer Res. 2012, 1(2):111-121.
11. Ozdemir V., Williams-Jones B., Glatt S.J., Tsuang M.T., Lohr J.B., Reist C. Shifting emphasis from pharmacogenomics to theranostics. Nat. Biotechnol. 2006, 24(8):942-946.
12. Park S., Parwani A.V., Aller R.D., Banach L., Becich M.J., Borkenfeld S., Carter A.B., Friedman B.A., Rojo M.G., Georgiou A., Kayser G., Kayser K., Legg M., Naugler C., Sawai T., Weiner H., Winsten D., Pantanowitz L. The history of pathology informatics: a global perspective. J.Pathol. Inform. 2013, 30(4):7. 10.4103/2153-3539.112689.
13. Salto-Tellez M., de Castro D.G. Next generation sequencing: a change of paradigm in molecular diagnostic validation. J.Pathol 2014, 10.1002/path.4365.
14. Stanta G., Cescato A., Bonin S., Barbazza R. Bioethics considerations for medical research in human archive tissues: the point of view of the researcher. Virchows Arch. 2008, 453(1):117-119.
15. Stanta G., Bonin S., Machado I., Llombart-Bosch A. Models of biobanking and tissue preservation: RNA quality in archival samples in pathology laboratories and "invivo biobanking" by tumor xenografts in nude mice-two models of quality assurance in pathology. Biopreserv. Biobank 2011, 9(2):149-155.
16. Simeon-Dubach D., Burt A.D., Hall P.A. Quality really matters: the need to improve specimen quality in biomedical research. J.Pathol Oct 1 2012, [Epub ahead of print]. 10.1002/path. 4117.
17. Simon R., Roychowdhury S. Implementing personalized cancer genomics in clinical trials. Nat. Rev. Drug Discov. 2013, 12(5):358-369.
18. Wheler J., Hong D., Swisher S.G., Falchook G., Tsimberidou A.M., Helgason T., Naing A., Stephen B., Janku F., Stephens P.J., Yelensky R., Kurzrock R. Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses. Oncotarget 2013, 4(6):890-898.